Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967240 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Vasodilator-Stimulated phosphoprotein (VASP) antibody
- Antibody type
- Polyclonal
- Antigen
- The antiserum was produced against synthesized non-phosphopeptide derived from human VASP around the phosphorylation site of serine 238 (K-V-SP-K-Q).
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100 μg
- Concentration
- 100ug/100ul.
- Storage
- -20°C
Submitted references Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins.
Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation.
Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody.
cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets.
Wang HG, Lu FM, Jin I, Udo H, Kandel ER, de Vente J, Walter U, Lohmann SM, Hawkins RD, Antonova I
Neuron 2005 Feb 3;45(3):389-403
Neuron 2005 Feb 3;45(3):389-403
Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
Jensen BO, Selheim F, Døskeland SO, Gear AR, Holmsen H
Blood 2004 Nov 1;104(9):2775-82
Blood 2004 Nov 1;104(9):2775-82
Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation.
Zhuang S, Nguyen GT, Chen Y, Gudi T, Eigenthaler M, Jarchau T, Walter U, Boss GR, Pilz RB
The Journal of biological chemistry 2004 Mar 12;279(11):10397-407
The Journal of biological chemistry 2004 Mar 12;279(11):10397-407
Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody.
Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H, Walter U
The Journal of biological chemistry 1998 Aug 7;273(32):20029-35
The Journal of biological chemistry 1998 Aug 7;273(32):20029-35
cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets.
Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J, Walter U
The Journal of biological chemistry 1994 May 20;269(20):14509-17
The Journal of biological chemistry 1994 May 20;269(20):14509-17
No comments: Submit comment
No validations: Submit validation data